Systematic Review: Levosimendan for Decompensated Congestive Heart Failure
16 May, 2019 | 05:38h | UTC“In patients with dilated cardiomyopathy and ejection fraction < 30% (heart failure post-intervention or not), levosimendan does not reduce the risk of death.”